Worldwide Fractional Flow Reserve Industry to 2027 - Increasing Number of Cath Labs is Driving Growth
July 07, 2022 05:28 ET
|
Research and Markets
Dublin, July 07, 2022 (GLOBE NEWSWIRE) -- The "Fractional Flow Reserve Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The fractional...
Autotransfusion Devices Market Size Worth $1.33Bn, Globally, by 2028 at 4.2% CAGR - Exclusive Report by The Insight Partners
April 07, 2022 11:21 ET
|
The Insight Partners
New York, April 07, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
The Worldwide Motorized Thrombectomy Industry is Expected to Reach $1 Billion in 2026
January 31, 2022 05:38 ET
|
Research and Markets
Dublin, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The "Motorized Thrombectomy Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global motorized...
Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET
|
Angion Biomedica Corp.
-- Topline data in ANG-3777 Phase 3 study now expected to be announced in early Q4 rather than at year end -- Phase 1 data demonstrated ANG-3070 was well-tolerated across dose cohorts, achieving drug...
Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
April 29, 2021 00:05 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y. and ST. GALLEN, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN) and Vifor Pharma today announced completion of enrollment for Angion’s AKI-002-15...
Renibus Therapeutics Initiates Phase 2 Study of RBT-1 for Prevention of Acute Kidney Injury
March 11, 2021 09:00 ET
|
Rénibus Therapeutics Inc.
- Renibus plans to enroll 126 subjects at up to 20 sites across the United States, Canada, Australia, and New Zealand DALLAS, Texas, March 11, 2021 (GLOBE NEWSWIRE) -- Renibus Therapeutics®...
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
March 04, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will...
Renibus Therapeutics Announces Abstract Presentation at the 2020 European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Annual Congress
June 09, 2020 09:00 ET
|
Rénibus Therapeutics Inc.
Dallas, June 09, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc, a clinical-stage biotechnology company, is pleased to announce that data highlighting the translation of the mechanism of action...
Cardiac surgery instruments Market To Reach USD 2.06 Billion By 2027 | Reports And Data
January 28, 2020 10:00 ET
|
Reports and Data
New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- The Global Cardiac Surgery Instruments Market is forecast to reach USD 2.06 Billion by 2027, according to a new report by Reports and Data. Cardiac...
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
September 24, 2019 16:01 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...